- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 281.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 281.69M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 264.63M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $16.14K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$327.98K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $241.96K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $152.72K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $43.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$51.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$49.77M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $72.94M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $17.43M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $75.18M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $63.21M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.73M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.58M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $30.09M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $19.84M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $622.85K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.22M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.68M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$2.72M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$622.85K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.78M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $4.65M |